OmniAb reported Q2 2026 revenue of $13.4 million, up from $3.9 million a year earlier, while net loss narrowed to $5.9 million from $15.9 million. The surge, driven by milestone and service revenue and higher xPloration instrument sales, lifts cash outlook and positions the firm for stronger full‑year earnings.
Key Highlights
- Q2 revenue rose to $13.4 million, up from $3.9 million YoY.
- Net loss contracted to $5.9 million, improving over prior‑year loss of $15.9 million.
- Full‑year outlook was raised.
- R&D expense fell to $9.6 million from $10.9 million, while G&A expense dropped to $6.7 million from $7.7 million.
OmniAb, Inc. posted second‑quarter revenue of $13.4 million, an increase from $3.9 million in the comparable period a year earlier, while its net loss narrowed to $5.9 million versus $15.9 million. The improvement was driven by milestone receipts, new ion‑channel service contracts and stronger xPloration instrument sales. The company also raised its full‑year outlook for both revenue and cash balances, reflecting confidence in its commercial momentum.
Investors view this as evidence that the firm’s discovery platform is gaining traction in the market.
Q2 Revenue Surge
Revenue for the second quarter of 2026 reached $13.4 million, up from $3.9 million a year earlier, driven by higher milestone income and the launch of new ion‑channel programs. Service revenue grew as partners engaged OmniAb’s expertise, and xPloration revenue increased due to greater instrument and consumable sales. The cost associated with xPloration revenue rose to $0.6 million from $0.3 million, highlighting expanding hardware adoption.
This top‑line growth suggests the platform is transitioning from research collaborations to revenue‑producing contracts, a shift that may accelerate cash generation.
Cost Structure Tightening
Research and development expense fell to $9.6 million, down from $10.9 million a year earlier, as share‑based compensation and salary costs declined. General and administrative expense decreased to $6.7 million from $7.7 million, reflecting lower professional fees and payroll items. Amortization of intangibles eased to $3.1 million compared with $3.2 million previously, indicating fewer non‑cash charges.
Total operating expenses remained at $20.1 million, while cash‑based operating costs rose modestly to $13.3 million from $11.9 million, tied to higher cash outlays for instrument sales. These dynamics show a mix of expense control and targeted investment for growth.
Outlook Revision Signals Growth
OmniAb adjusted its 2026 outlook, indicating higher expected revenue and a stronger cash position. The revised guidance reflects confidence that recent partner milestones and expanding xPloration sales will sustain momentum. An improved cash runway enhances liquidity, lowering financing risk and providing flexibility to fund ongoing programs.
Upcoming Investor Day as Catalyst
The firm announced an Investor and Analyst Day in October, where it will detail progress on the xPloration platform and partner pipelines. Management is expected to discuss recent advances in key programs, offering insight into future revenue streams. The event will also address plans to meet revised expense targets while scaling discovery services.
Analysts will watch for forward‑looking statements that could further adjust the outlook, making the meeting a key market catalyst.
Analysis based on the Form 8-K filed 6 August 2026; figures verified against the filing.
This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making investment decisions.



_11_19_2026_18_10_09_455845.jpg)

_11_19_2026_18_15_38_890267.jpg)
Please wait processing your request...